Discovery Science
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could affect disease risk and severity. Their research could lead to new therapies in the future.
Latest stories
Biotherapeutics
February 10, 2021
Individualized Medicine
February 6, 2021
Research
February 3, 2021
COVID-19
February 1, 2021
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community